Crossref
journal-article
Ovid Technologies (Wolters Kluwer Health)
Pharmacogenetics and Genomics (276)
References
36
Referenced
391
10.1016/S0959-437X(96)80091-8
/ Curr Opin Genet Dev / P-glycoprotein and multidrug resistance by Gottesman (1996){'key': 'R2-3-20210212', 'first-page': 'RA5', 'article-title': 'Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction', 'volume': '10', 'author': 'Sun', 'year': '2004', 'journal-title': 'Med Sci Monit'}
/ Med Sci Monit / Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction by Sun (2004)10.1007/s00210-003-0813-5
/ Naunyn Schmiedebergs Arch Pharmacol / Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution by Gerloff (2004)10.1073/pnas.97.7.3473
/ Proc Natl Acad Sci USA / Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo by Hoffmeyer (2000)10.1097/00008571-200308000-00006
/ Pharmacogenetics / Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene by Kroetz (2003)10.1101/gr.1965304
/ Genome Res / Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene by Soranzo (2004)10.1016/j.amjcard.2004.01.014
/ Am J Cardiol / Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner by Kajinami (2004)10.1097/01.TP.0000130981.55654.78
/ Transplantation / MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients by Bonhomme-Faivre (2004)10.1001/archneur.62.3.460
/ Arch Neurol / Effect of MDR1 haplotype on risk of Parkinson disease by Tan (2005)10.1053/gast.2003.50010
/ Gastroenterology / Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis by Schwab (2003)10.1053/j.gastro.2004.11.019
/ Gastroenterology / Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis by Ho (2005)10.1056/NEJMoa021986
/ N Engl J Med / Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1 by Siddiqui (2003)10.1016/j.clpt.2003.09.012
/ Clin Pharmacol Ther / Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance by Marzolini (2004)10.1111/j.1600-0609.2004.00228.x
/ Eur J Haematol / Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia by Jamroziak (2004)10.1016/S0140-6736(02)07276-8
/ Lancet / Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study by Fellay (2002)10.1016/S0009-9236(03)00234-0
/ Clin Pharmacol Ther / No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects by Pauli-Magnus (2003){'key': 'R17-3-20210212', 'first-page': '531', 'article-title': 'No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment', 'volume': '8', 'author': 'Winzer', 'year': '2003', 'journal-title': 'Eur J Med Res'}
/ Eur J Med Res / No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment by Winzer (2003)10.1111/j.1365-2125.2003.02061.x
/ Br J Clin Pharmacol / Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes by Yasui-Furukori (2004)10.1023/B:PHAM.0000029276.21063.0b
/ Pharm Res / Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1) by Pauli-Magnus (2004)10.1517/14622416.6.2.115
/ Pharmacogenomics / Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2 by Lepper (2005)10.1126/science.1101659
/ Science / Cis-acting regulatory variation in the human genome by Pastinen (2004)10.1016/j.pharmthera.2004.11.001
/ Pharmacol Ther / Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics by Johnson (2005)10.1124/jpet.104.069724
/ J Pharmacol Exp Ther / Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene by Takane (2004)10.1016/S0959-437X(00)00250-1
/ Curr Opin Genet Dev / Gene expression and molecular evolution by Akashi (2001)10.1016/S0378-1119(00)00482-0
/ Gene / A test of translational selection at ‘silent’ sites in the human genome: base composition comparisons in alternatively spliced genes by Iida (2000)10.1093/genetics/159.2.623
/ Genetics / The relationship between third-codon position nucleotide content, codon bias, mRNA secondary structure and gene expression in the drosophilid alcohol dehydrogenase genes Adh and Adhr by Carlini (2001)10.1093/hmg/ddg055
/ Hum Mol Genet / Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor by Duan (2003)10.1124/jpet.104.073098
/ J Pharmacol Exp Ther / Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions by Pinsonneault (2004)10.1093/nar/gkg595
/ Nucleic Acids Res / Mfold web server for nucleic acid folding and hybridization prediction by Zuker (2003)10.1017/S1355838298980116
/ Rna / Using reliability information to annotate RNA secondary structures by Zuker (1998)10.1016/S0006-2952(03)00242-9
/ Biochem Pharmacol / Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2 by Goto (2003)10.1097/00008571-200405000-00006
/ Pharmacogenetics / Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1) by Hitzl (2004){'key': 'R33-3-20210212', 'first-page': '564', 'article-title': 'Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells', 'volume': '87', 'author': 'Calado', 'year': '2002', 'journal-title': 'Haematologica'}
/ Haematologica / Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells by Calado (2002)10.1124/mol.62.1.1
/ Mol Pharmacol / Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system by KimchiSarfaty (2002)10.1111/j.1365-2125.2005.02229.x
/ Br J Clin Pharmacol / Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver by Owen (2005)10.1067/mcp.2001.117412
/ Clin Pharmacol Ther / Identification of functionally variant MDR1 alleles among European Americans and African Americans by Kim (2001)
Dates
Type | When |
---|---|
Created | 16 years, 6 months ago (March 4, 2009, 1:52 p.m.) |
Deposited | 3 years, 11 months ago (Oct. 2, 2021, 1:13 p.m.) |
Indexed | 3 days, 9 hours ago (Sept. 3, 2025, 6:24 a.m.) |
Issued | 19 years, 11 months ago (Oct. 1, 2005) |
Published | 19 years, 11 months ago (Oct. 1, 2005) |
Published Print | 19 years, 11 months ago (Oct. 1, 2005) |
@article{Wang_2005, title={Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability}, volume={15}, ISSN={1744-6872}, url={http://dx.doi.org/10.1097/01.fpc.0000178311.02878.83}, DOI={10.1097/01.fpc.0000178311.02878.83}, number={10}, journal={Pharmacogenetics and Genomics}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Wang, Danxin and Johnson, Andrew D. and Papp, Audrey C. and Kroetz, Deanna L. and Sadée, Wolfgang}, year={2005}, month=oct, pages={693–704} }